← All tickers

Is AIM Worth Buying in 2026?

AIM ImmunoTech Inc.

STOCK BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Updated 2026-05-24

Here’s whether AIM ImmunoTech Inc. (AIM) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: strong 1-year return of +97.8%. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-13.40% over 10 days); 3-month momentum negative (-77.8%); rising volume on a downtrend (distribution, 2.90x avg). Currently 98.8% off its 52-week high. Score: -4/7.

Ready to act on this? 📈 Trade on Webull

AIM is trading below its 200-day MA ($1.48) — a key warning sign the longer-term trend is under pressure. An RSI of 31.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +97.8% compares to +27.9% for SPY (beat the market by 70.0%). The current 98.8% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $19,783 today
vs. S&P 500 (SPY) — same period beat market by 70.0%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✗Above 200-day MA ($1.48)
✗Above 50-day MA ($0.55)
✓RSI(14) neutral zone (30–70) — currently 31.5
✓Positive return (+97.8%)
!Within 10% of period high (−98.8%)
Period Range $0.24
$0.06 $20.33
RSI (14) 31.5
0 · OversoldOverbought · 100

Key Metrics

Price$0.24
Period Return+97.8%
Period High$20.33
Period Low$0.06
Drawdown−98.8%
MA-50$0.55
MA-200$1.48
RSI (14)31.5
Avg Volume (30d)17.7M
vs. SPYbeat by 70.0%
Return Rank#223 of 1236

Trade AIM

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers